Glycan-Modified Virus-like Particles Evoke T Helper Type 1-like Immune Responses-Reference-Cited by-同舟云学术

Glycan-Modified Virus-like Particles Evoke T Helper Type 1-like Immune Responses

Published:2020-08-06 Issue:1 Volume:15 Page:309-321
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Alam Mohammad Murshid¹^ORCID,Jarvis Cassie M.¹^ORCID,Hincapie Robert²,McKay Craig S.²,Schimer Jiri²,Sanhueza Carlos A.²,Xu Ke,Diehl Roger C.¹,Finn M. G.²^ORCID,Kiessling Laura L.¹^ORCID

Affiliation:

1. Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States

2. School of Chemistry and Biochemistry, Georgia Institute of Technology, 901 Atlantic Drive, Atlanta, Georgia 30332, United States

Funder

National Institute of Allergy and Infectious Diseases

Publisher

American Chemical Society (ACS)

Subject

General Physics and Astronomy,General Engineering,General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsnano.0c03023

Reference75 articles.

1. Dendritic cell regulation of TH1-TH2 development

2. Glycan-Based Cell Targeting To Modulate Immune Responses

3. Multivalent glycopeptide dendrimers for the targeted delivery of antigens to dendritic cells

4. C-type lectin receptors in the control of T helper cell differentiation

5. Identification of DC-SIGN, a Novel Dendritic Cell–Specific ICAM-3 Receptor that Supports Primary Immune Responses

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CO-DELIVERY of glutamic acid-extended peptide antigen and imidazoquinoline TLR7/8 agonist via ionizable lipid nanoparticles induces protective anti-tumor immunity;Biomaterials;2024-12

2. Current advance of nanotechnology in diagnosis and treatment for malignant tumors;Signal Transduction and Targeted Therapy;2024-08-12

3. Heterologous Prime-Boost with Immunologically Orthogonal Protein Nanoparticles for Peptide Immunofocusing;ACS Nano;2024-07-23

4. Components, Formulations, Deliveries, and Combinations of Tumor Vaccines;ACS Nano;2024-07-09

5. Toward innovative veterinary nanoparticle vaccines;Animal Diseases;2024-05-10